WallStreetZenWallStreetZen

NASDAQ: CDXS
Codexis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CDXS stock forecasts and price targets.

Forecast return on equity

Is CDXS forecast to generate an efficient return?

Company
-64.33%
Industry
92.89%
Market
174.26%
CDXS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CDXS forecast to generate an efficient return on assets?

Company
-21.5%
Industry
28.09%
CDXS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CDXS earnings per share forecast

What is CDXS's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$0.41
Avg 2 year Forecast
-$0.38
Avg 3 year Forecast
-$0.27

CDXS revenue forecast

What is CDXS's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$76.3M-2.33%
Avg 2 year Forecast
$92.0M+17.76%
Avg 3 year Forecast
$107.7M+37.95%
CDXS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDXS revenue growth forecast

How is CDXS forecast to perform vs Biotechnology companies and vs the US market?

Company
11.32%
Industry
35.02%
Market
13.5%
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDXS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDXS$2.56N/AN/A
OBIO$3.90$13.60+248.72%Strong Buy
TARA$4.16$25.60+515.38%Strong Buy
NERV$4.96$10.50+111.69%Buy
FATE$1.98$7.00+253.54%Buy
View Top Biotech Stocks

Codexis Stock Forecast FAQ

What is CDXS's earnings growth forecast for 2026-2028?

(NASDAQ: CDXS) Codexis's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.72%.

Codexis's earnings in 2026 is -$31,990,000.On average, 9 Wall Street analysts forecast CDXS's earnings for 2026 to be -$37,085,799, with the lowest CDXS earnings forecast at -$40,976,172, and the highest CDXS earnings forecast at -$33,404,488. On average, 8 Wall Street analysts forecast CDXS's earnings for 2027 to be -$34,922,461, with the lowest CDXS earnings forecast at -$36,522,241, and the highest CDXS earnings forecast at -$33,404,488.

In 2028, CDXS is forecast to generate -$24,105,770 in earnings, with the lowest earnings forecast at -$23,160,445 and the highest earnings forecast at -$24,814,763.

If you're new to stock investing, here's how to buy Codexis stock.

What is CDXS's revenue growth forecast for 2026-2028?

(NASDAQ: CDXS) Codexis's forecast annual revenue growth rate of 11.32% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.5%.

Codexis's revenue in 2026 is $78,092,000.On average, 9 Wall Street analysts forecast CDXS's revenue for 2026 to be $6,932,590,269, with the lowest CDXS revenue forecast at $6,573,367,036, and the highest CDXS revenue forecast at $7,234,457,768. On average, 8 Wall Street analysts forecast CDXS's revenue for 2027 to be $8,359,030,094, with the lowest CDXS revenue forecast at $7,215,369,488, and the highest CDXS revenue forecast at $10,394,022,436.

In 2028, CDXS is forecast to generate $9,792,287,163 in revenue, with the lowest revenue forecast at $8,221,958,071 and the highest revenue forecast at $11,352,072,253.

What is CDXS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CDXS) forecast ROA is -21.5%, which is lower than the forecast US Biotechnology industry average of 28.09%.

What is CDXS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CDXS) Codexis's current Earnings Per Share (EPS) is -$0.36. On average, analysts forecast that CDXS's EPS will be -$0.41 for 2026, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.37. On average, analysts forecast that CDXS's EPS will be -$0.38 for 2027, with the lowest EPS forecast at -$0.40, and the highest EPS forecast at -$0.37. In 2028, CDXS's EPS is forecast to hit -$0.27 (min: -$0.25, max: -$0.27).

What is CDXS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CDXS) forecast ROE is -64.33%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.